These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20558046)

  • 1. In vitro activity of tigecycline against carbapenemase-producing Acinetobacter baumannii.
    Hawser SP; Hackel M; Person MB; Higgins PG; Seifert H; Dowzicky M
    Int J Antimicrob Agents; 2010 Sep; 36(3):289-90. PubMed ID: 20558046
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii.
    Capone A; D'Arezzo S; Visca P; Petrosillo N;
    J Antimicrob Chemother; 2008 Aug; 62(2):422-3. PubMed ID: 18424790
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative in vitro activities of tigecycline and 11 other antimicrobial agents against 215 epidemiologically defined multidrug-resistant Acinetobacter baumannii isolates.
    Seifert H; Stefanik D; Wisplinghoff H
    J Antimicrob Chemother; 2006 Nov; 58(5):1099-100. PubMed ID: 16980293
    [No Abstract]   [Full Text] [Related]  

  • 4. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan.
    Liu JW; Wang LS; Cheng YJ; Hsu GJ; Lu PL; Liu YC; Chen CM; Lee CM; Sun W; Jang TN; Chiang PC; Chuang YC; Lin HC; Shi ZY; Kung HC; Huang CH; Tsao SM; Lu CT; Liao CH; Hsueh PR
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S188-91. PubMed ID: 19013353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of an extreme-drug-resistant (XDR) Acinetobacter baumannii carrying blaOXA-23 in a patient with acute necrohaemorrhagic pancreatitis.
    Grosso F; Quinteira S; Peixe L
    J Hosp Infect; 2010 May; 75(1):82-3. PubMed ID: 20303617
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the Etest and broth microdilution method for tigecycline susceptibility testing against clinical isolates of Acinetobacter baumannii from Taiwan.
    Liu JW; Jang TN; Cheng YJ; Hsu GJ; Sun W; Lu CT; Hsueh PR;
    Int J Antimicrob Agents; 2010 Feb; 35(2):201-2. PubMed ID: 19892530
    [No Abstract]   [Full Text] [Related]  

  • 7. Isolation of uncommon respiratory and enteric Acinetobacter baumannii from hematologic patients and emergence of tigecycline-resistance.
    Savini V; Catavitello C; Pompetti F; Talia M; Costanzi L; Balbinot A; Febbo F; Di Zacomo S; Esattore F; D'Antonio D
    J Infect; 2008 Dec; 57(6):497-500. PubMed ID: 19027170
    [No Abstract]   [Full Text] [Related]  

  • 8. Postantibiotic effects of tigecycline, colistin sulfate, and levofloxacin alone or tigecycline-colistin sulfate and tigecycline-levofloxacin combinations against Acinetobacter baumannii.
    Ozbek B; Sentürk A
    Chemotherapy; 2010; 56(6):466-71. PubMed ID: 21088399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbapenem-resistant Acinetobacter baumannii producing OXA-23 in Thailand.
    Niumsup PR; Boonkerd N; Tansawai U; Tiloklurs M
    Jpn J Infect Dis; 2009 Mar; 62(2):152-4. PubMed ID: 19305059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant prevention concentration of tigecycline for carbapenem-susceptible and -resistant Acinetobacter baumannii.
    Cui JC; Liu YN; Chen LA
    J Antibiot (Tokyo); 2010 Jan; 63(1):29-31. PubMed ID: 19911030
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro activities of tigecycline alone and in combination with colistin sulfate or sulbactam against carbapenem-susceptible and -resistant Acinetobacter baumannii strains isolated from Intensive Care Units.
    Ozbek B; Otük G
    Int J Antimicrob Agents; 2010 Aug; 36(2):191-2. PubMed ID: 20537868
    [No Abstract]   [Full Text] [Related]  

  • 12. Outbreak in Croatia caused by a new carbapenem-resistant clone of Acinetobacter baumannii producing OXA-72 carbapenemase.
    Goic-Barisic I; Towner KJ; Kovacic A; Sisko-Kraljevic K; Tonkic M; Novak A; Punda-Polic V
    J Hosp Infect; 2011 Apr; 77(4):368-9. PubMed ID: 21316806
    [No Abstract]   [Full Text] [Related]  

  • 13. Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India.
    Karthikeyan K; Thirunarayan MA; Krishnan P
    J Antimicrob Chemother; 2010 Oct; 65(10):2253-4. PubMed ID: 20650909
    [No Abstract]   [Full Text] [Related]  

  • 14. Antimicrobial susceptibility of extended-spectrum beta-lactamase producers and multidrug-resistant Acinetobacter baumannii throughout the United States and comparative in vitro activity of tigecycline, a new glycylcycline antimicrobial.
    Hoban DJ; Bouchillon SK; Dowzicky MJ
    Diagn Microbiol Infect Dis; 2007 Apr; 57(4):423-8. PubMed ID: 17403448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of carbapenem-resistant Acinetobacter baumannii isolates in a district hospital in Taiwan.
    Chen CM; Liu PY; Ke SC; Wu HJ; Wu LT
    Diagn Microbiol Infect Dis; 2009 Apr; 63(4):394-7. PubMed ID: 19302926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases.
    Tripodi MF; Durante-Mangoni E; Fortunato R; Utili R; Zarrilli R
    Int J Antimicrob Agents; 2007 Dec; 30(6):537-40. PubMed ID: 17851050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.
    Navon-Venezia S; Leavitt A; Carmeli Y
    J Antimicrob Chemother; 2007 Apr; 59(4):772-4. PubMed ID: 17353223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diversity of plasmid-mediated carbapenem-hydrolysing oxacillinases among carbapenem-resistant Acinetobacter baumannii isolates from Kingdom of Bahrain.
    Mugnier PD; Bindayna KM; Poirel L; Nordmann P
    J Antimicrob Chemother; 2009 May; 63(5):1071-3. PubMed ID: 19252183
    [No Abstract]   [Full Text] [Related]  

  • 19. Dissemination of OXA-carbapenemase-producing Acinetobacter baumannii ST195 and ST642 in a Mongolian hospital.
    Kao CY; Udval U; Oyunchimeg R; Wu HM; Huang AH; Bolormaa E; Munkhtuya E; Yan JJ; Batbaatar G; Khosbayar T; Wu JJ
    Infect Genet Evol; 2014 Dec; 28():313-6. PubMed ID: 25445647
    [No Abstract]   [Full Text] [Related]  

  • 20. Outbreaks of imipenem-resistant Acinetobacter baumannii producing carbapenemases in Korea.
    Jeong SH; Bae IK; Park KO; An YJ; Sohn SG; Jang SJ; Sung KH; Yang KS; Lee K; Young D; Lee SH
    J Microbiol; 2006 Aug; 44(4):423-31. PubMed ID: 16953178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.